The Impact of Doulas in Early Pregnancy Management

January 6, 2016 updated by: Courtney Schreiber, University of Pennsylvania

The Impact of Doulas in the Surgical Management of Early Pregnancy Failure and Abortion Care

The purpose of the study is to examine the impact of doula support for women undergoing a manual vacuum aspiration (MVA) for an early pregnancy failure or undesired pregnancy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

As a means of providing emotional support and physical comfort for all pregnant women, doulas have emerged in recent years in the world of clinical abortion care. Traditionally, doulas are non-medical individuals trained to provide emotional support, pain management strategies, relaxation techniques, and information to pregnant women during labor. The positive impact of doulas on obstetrical health outcomes and patient satisfaction is well accepted.

Women with the support of a doula have been shown to have shorter labor, and rate birth as less difficult and more satisfying, than do mothers without doula support. They also report a greater ability to cope with labor and require less epidural and IV pain medication. In recent years, the term full spectrum doula has emerged to describe doulas who extend their supportive services to women at any stage of a pregnancy, including the management of a miscarriage or undesired pregnancy ending in abortion. The Doula Project, created in 2007 in New York City, and the Bay Area Doula Project, founded in 2011in San Francisco, were two of the first organized efforts to train doulas to provide abortion care and are now the largest in the United States. Scientific research on the impact of doulas during abortion and miscarriage management has been limited, but anecdotal reports from patients and providers suggest a positive impact on patient satisfaction. In this study we aim to test the impact of doulas on the physical, emotional, and overall experience among women undergoing a MVA for an early pregnancy failure or undesired pregnancy at the Penn Family Planning and Pregnancy Loss Center. We also aim to assess the impact of doula support from the medical assistants perception.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Penn Family Planning and Pregnancy Loss Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female 18 years or older who is choosing to have a surgical procedure for the management of early pregnancy failure or undesired pregnancy.
  • Pregnancy is not because of an incident of sexual assault or rape.

Exclusion Criteria:

  • Pregnancy is due to an incident of sexual assault or rape.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Doula
Patients will have a doula support person during their procedure.
A specially trained support person or doula will accompany the patient to offer physical and emotional support during the procedure.
No Intervention: Routine care/No Doula
Patients will have routine care with clinical staff only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The degree of physical discomfort reported by women during their MVA procedure.
Time Frame: At enrollment baseline
This data is obtained in-clinic via a brief questionnaire after the patient undergoes the MVA at enrollment baseline.
At enrollment baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The degree to which women report the ability to emotionally cope with their MVA procedure.
Time Frame: At baseline visit and at 1-month follow-up
This data was obtained via a brief questionnaire before and after the MVA at enrollment baseline, and then via a brief survey completed over the phone 1 month after enrollment.
At baseline visit and at 1-month follow-up
The degree to which women sense empowerment before and following their MVA procedure
Time Frame: At enrollment baseline and 1-month follow-up
This data was obtained via a brief questionnaire before and after the MVA at enrollment baseline, and then via a brief survey completed over the phone 1 month after enrollment.
At enrollment baseline and 1-month follow-up
A rating of the emotional response experienced by women before and after their MVA procedure.
Time Frame: At enrollment baseline and 1-month follow up
This data was obtained via a brief questionnaire before and after the MVA at enrollment baseline, and then via a brief survey completed over the phone 1 month after enrollment.
At enrollment baseline and 1-month follow up
The degree to which women are satisfied by their MVA procedure experience
Time Frame: At enrollment baseline and 1-month follow-up
This data was obtained via a brief questionnaire after the MVA at enrollment baseline, and then via a brief survey completed over the phone 1 month after enrollment.
At enrollment baseline and 1-month follow-up
The degree to which medical assistant reports a more positive or negative patient and personal experience with the MVA procedure
Time Frame: At enrollment baseline
This data will be obtained via a Visual Analog Scale administered after the MVA procedure.
At enrollment baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Courtney Schreiber, MD, MPH, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

May 19, 2014

First Submitted That Met QC Criteria

June 16, 2014

First Posted (Estimate)

June 17, 2014

Study Record Updates

Last Update Posted (Estimate)

January 8, 2016

Last Update Submitted That Met QC Criteria

January 6, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 819173

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uterine Evacuation

Clinical Trials on Doula

Subscribe